世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000040566

気管支拡張症治療薬の世界市場(2024-2028)

TechNavio

Global Bronchiectasis Drugs Market 2024-2028

発刊日 2024/07/12

言語英語

体裁PDF/174ページ

ライセンス/価格174ページ

0000040566

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。電子媒体での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

気管支拡張症治療薬市場は、2023年から2028年にかけて3億9,410万米ドル、予測期間中のCAGRは10.87%で成長すると予測されています。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。

このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。市場は、関連リスク因子の症例増加、低コストの適応外ジェネリック医薬品の入手可能性、老年人口の急増によって牽引されています。

調査範囲

  • 市場セグメント
    ➣ 製品別
      ◇ 抗生物質
      ◇ 去痰薬
      ◇ その他
    ➣ 流通チャネル別
      ◇ オフライン
      ◇ オンライン
    ➣ 地域別
      ◇ 北アメリカ
      ◇ ヨーロッパ
      ◇ アジア
      ◇ その他の地域

この調査は、気管支拡張症に対する意識の高まりが、今後数年間の気管支拡張症治療薬市場の成長を促進する主な理由の1つであることを特定しています。また、呼吸器疾患の診断の進歩と標的療法への需要の高まりにより、市場での大きな需要が見込まれるでしょう。

気管支拡張症治療薬市場に関するレポートは、次の分野をカバーしています。

  • 気管支拡張症治療薬市場の規模
  • 気管支拡張症治療薬市場の予測
  • 気管支拡張症治療薬市場の業界分析

堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されています。

  • 調査企業
    ➣ AbbVie Inc.
    ➣ Akorn Operating Co. LLC
    ➣ Amneal Pharmaceuticals Inc.
    ➣ Aurobindo Pharma Ltd.
    ➣ Bayer AG
    ➣ Boehringer Ingelheim International GmbH
    ➣ DR Reddys Laboratories Ltd.
    ➣ Endo International PLC
    ➣ GlaxoSmithKline PLC
    ➣ Hikma Pharmaceuticals PLC
    ➣ Lupin Ltd.
    ➣ Neopharma Corp.
    ➣ Pfizer Inc.
    ➣ Reckitt Benckiser Group PLC
    ➣ Sun Pharmaceutical Industries Ltd.
    ➣ Teva Pharmaceutical Industries Ltd.
    ➣ Viatris Inc.
    ➣ Virtus Pharmaceuticals LLC
    ➣ Wockhardt Ltd.
    ➣ Zydus Lifesciences Ltd.

また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。

このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Product
Executive Summary - Chart on Market Segmentation by Distribution Channel
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning

2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis

3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global Bronchiectasis Drugs Market 2018 - 2022
Historic Market Size - Data Table on Global Bronchiectasis Drugs Market 2018 - 2022 ($ million)
4.2 Product segment analysis 2018 - 2022
Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.3 Distribution Channel segment analysis 2018 - 2022
Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product
6.1 Market segments
Chart on Product - Market share 2023-2028 (%)
Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
Chart on Comparison by Product
Data Table on Comparison by Product
6.3 Antibiotics - Market size and forecast 2023-2028
Chart on Antibiotics - Market size and forecast 2023-2028 ($ million)
Data Table on Antibiotics - Market size and forecast 2023-2028 ($ million)
Chart on Antibiotics - Year-over-year growth 2023-2028 (%)
Data Table on Antibiotics - Year-over-year growth 2023-2028 (%)
6.4 Expectorants - Market size and forecast 2023-2028
Chart on Expectorants - Market size and forecast 2023-2028 ($ million)
Data Table on Expectorants - Market size and forecast 2023-2028 ($ million)
Chart on Expectorants - Year-over-year growth 2023-2028 (%)
Data Table on Expectorants - Year-over-year growth 2023-2028 (%)
6.5 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ million)
Data Table on Others - Market size and forecast 2023-2028 ($ million)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Product
Market opportunity by Product ($ million)
Data Table on Market opportunity by Product ($ million)

7 Market Segmentation by Distribution Channel
7.1 Market segments
Chart on Distribution Channel - Market share 2023-2028 (%)
Data Table on Distribution Channel - Market share 2023-2028 (%)
7.2 Comparison by Distribution Channel
Chart on Comparison by Distribution Channel
Data Table on Comparison by Distribution Channel
7.3 Offline - Market size and forecast 2023-2028
Chart on Offline - Market size and forecast 2023-2028 ($ million)
Data Table on Offline - Market size and forecast 2023-2028 ($ million)
Chart on Offline - Year-over-year growth 2023-2028 (%)
Data Table on Offline - Year-over-year growth 2023-2028 (%)
7.4 Online - Market size and forecast 2023-2028
Chart on Online - Market size and forecast 2023-2028 ($ million)
Data Table on Online - Market size and forecast 2023-2028 ($ million)
Chart on Online - Year-over-year growth 2023-2028 (%)
Data Table on Online - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Distribution Channel
Market opportunity by Distribution Channel ($ million)
Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.11 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints

11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business

12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 AbbVie Inc.
AbbVie Inc. - Overview
AbbVie Inc. - Product / Service
AbbVie Inc. - Key news
AbbVie Inc. - Key offerings
12.4 Akorn Operating Co. LLC
Akorn Operating Co. LLC - Overview
Akorn Operating Co. LLC - Product / Service
Akorn Operating Co. LLC - Key offerings
12.5 Amneal Pharmaceuticals Inc.
Amneal Pharmaceuticals Inc. - Overview
Amneal Pharmaceuticals Inc. - Business segments
Amneal Pharmaceuticals Inc. - Key news
Amneal Pharmaceuticals Inc. - Key offerings
Amneal Pharmaceuticals Inc. - Segment focus
12.6 Aurobindo Pharma Ltd.
Aurobindo Pharma Ltd. - Overview
Aurobindo Pharma Ltd. - Product / Service
Aurobindo Pharma Ltd. - Key offerings
12.7 Bayer AG
Bayer AG - Overview
Bayer AG - Business segments
Bayer AG - Key news
Bayer AG - Key offerings
Bayer AG - Segment focus
12.8 Boehringer Ingelheim International GmbH
Boehringer Ingelheim International GmbH - Overview
Boehringer Ingelheim International GmbH - Product / Service
Boehringer Ingelheim International GmbH - Key news
Boehringer Ingelheim International GmbH - Key offerings
12.9 Dr Reddys Laboratories Ltd.
Dr Reddys Laboratories Ltd. - Overview
Dr Reddys Laboratories Ltd. - Business segments
Dr Reddys Laboratories Ltd. - Key news
Dr Reddys Laboratories Ltd. - Key offerings
Dr Reddys Laboratories Ltd. - Segment focus
12.10 Endo International Plc
Endo International Plc - Overview
Endo International Plc - Business segments
Endo International Plc - Key news
Endo International Plc - Key offerings
Endo International Plc - Segment focus
12.11 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
12.12 Hikma Pharmaceuticals Plc
Hikma Pharmaceuticals Plc - Overview
Hikma Pharmaceuticals Plc - Business segments
Hikma Pharmaceuticals Plc - Key news
Hikma Pharmaceuticals Plc - Key offerings
Hikma Pharmaceuticals Plc - Segment focus
12.13 Lupin Ltd.
Lupin Ltd. - Overview
Lupin Ltd. - Product / Service
Lupin Ltd. - Key news
Lupin Ltd. - Key offerings
12.14 Neopharma Corp.
Neopharma Corp. - Overview
Neopharma Corp. - Product / Service
Neopharma Corp. - Key news
Neopharma Corp. - Key offerings
12.15 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
12.16 Reckitt Benckiser Group Plc
Reckitt Benckiser Group Plc - Overview
Reckitt Benckiser Group Plc - Business segments
Reckitt Benckiser Group Plc - Key news
Reckitt Benckiser Group Plc - Key offerings
Reckitt Benckiser Group Plc - Segment focus
12.17 Viatris Inc.
Viatris Inc. - Overview
Viatris Inc. - Business segments
Viatris Inc. - Key news
Viatris Inc. - Key offerings
Viatris Inc. - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Parent Market
Exhibits11: Data Table on - Parent Market
Exhibits12: Market characteristics analysis
Exhibits13: Value Chain Analysis
Exhibits14: Offerings of companies included in the market definition
Exhibits15: Market segments
Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits20: Historic Market Size - Data Table on Global Bronchiectasis Drugs Market 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits25: Five forces analysis - Comparison between 2023 and 2028
Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits31: Chart on Market condition - Five forces 2023 and 2028
Exhibits32: Chart on Product - Market share 2023-2028 (%)
Exhibits33: Data Table on Product - Market share 2023-2028 (%)
Exhibits34: Chart on Comparison by Product
Exhibits35: Data Table on Comparison by Product
Exhibits36: Chart on Antibiotics - Market size and forecast 2023-2028 ($ million)
Exhibits37: Data Table on Antibiotics - Market size and forecast 2023-2028 ($ million)
Exhibits38: Chart on Antibiotics - Year-over-year growth 2023-2028 (%)
Exhibits39: Data Table on Antibiotics - Year-over-year growth 2023-2028 (%)
Exhibits40: Chart on Expectorants - Market size and forecast 2023-2028 ($ million)
Exhibits41: Data Table on Expectorants - Market size and forecast 2023-2028 ($ million)
Exhibits42: Chart on Expectorants - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on Expectorants - Year-over-year growth 2023-2028 (%)
Exhibits44: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits45: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits46: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits47: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits48: Market opportunity by Product ($ million)
Exhibits49: Data Table on Market opportunity by Product ($ million)
Exhibits50: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits51: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits52: Chart on Comparison by Distribution Channel
Exhibits53: Data Table on Comparison by Distribution Channel
Exhibits54: Chart on Offline - Market size and forecast 2023-2028 ($ million)
Exhibits55: Data Table on Offline - Market size and forecast 2023-2028 ($ million)
Exhibits56: Chart on Offline - Year-over-year growth 2023-2028 (%)
Exhibits57: Data Table on Offline - Year-over-year growth 2023-2028 (%)
Exhibits58: Chart on Online - Market size and forecast 2023-2028 ($ million)
Exhibits59: Data Table on Online - Market size and forecast 2023-2028 ($ million)
Exhibits60: Chart on Online - Year-over-year growth 2023-2028 (%)
Exhibits61: Data Table on Online - Year-over-year growth 2023-2028 (%)
Exhibits62: Market opportunity by Distribution Channel ($ million)
Exhibits63: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits65: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits66: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits67: Chart on Geographic comparison
Exhibits68: Data Table on Geographic comparison
Exhibits69: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits70: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits71: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits72: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits73: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits86: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits87: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits90: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits91: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits94: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits95: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits98: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits99: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits101: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits102: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits103: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits104: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits105: Market opportunity By Geographical Landscape ($ million)
Exhibits106: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits107: Impact of drivers and challenges in 2023 and 2028
Exhibits108: Overview on criticality of inputs and factors of differentiation
Exhibits109: Overview on factors of disruption
Exhibits110: Impact of key risks on business
Exhibits111: Companies covered
Exhibits112: Matrix on companies position and classification
Exhibits113: AbbVie Inc. - Overview
Exhibits114: AbbVie Inc. - Product / Service
Exhibits115: AbbVie Inc. - Key news
Exhibits116: AbbVie Inc. - Key offerings
Exhibits117: Akorn Operating Co. LLC - Overview
Exhibits118: Akorn Operating Co. LLC - Product / Service
Exhibits119: Akorn Operating Co. LLC - Key offerings
Exhibits120: Amneal Pharmaceuticals Inc. - Overview
Exhibits121: Amneal Pharmaceuticals Inc. - Business segments
Exhibits122: Amneal Pharmaceuticals Inc. - Key news
Exhibits123: Amneal Pharmaceuticals Inc. - Key offerings
Exhibits124: Amneal Pharmaceuticals Inc. - Segment focus
Exhibits125: Aurobindo Pharma Ltd. - Overview
Exhibits126: Aurobindo Pharma Ltd. - Product / Service
Exhibits127: Aurobindo Pharma Ltd. - Key offerings
Exhibits128: Bayer AG - Overview
Exhibits129: Bayer AG - Business segments
Exhibits130: Bayer AG - Key news
Exhibits131: Bayer AG - Key offerings
Exhibits132: Bayer AG - Segment focus
Exhibits133: Boehringer Ingelheim International GmbH - Overview
Exhibits134: Boehringer Ingelheim International GmbH - Product / Service
Exhibits135: Boehringer Ingelheim International GmbH - Key news
Exhibits136: Boehringer Ingelheim International GmbH - Key offerings
Exhibits137: Dr Reddys Laboratories Ltd. - Overview
Exhibits138: Dr Reddys Laboratories Ltd. - Business segments
Exhibits139: Dr Reddys Laboratories Ltd. - Key news
Exhibits140: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits141: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits142: Endo International Plc - Overview
Exhibits143: Endo International Plc - Business segments
Exhibits144: Endo International Plc - Key news
Exhibits145: Endo International Plc - Key offerings
Exhibits146: Endo International Plc - Segment focus
Exhibits147: GlaxoSmithKline Plc - Overview
Exhibits148: GlaxoSmithKline Plc - Business segments
Exhibits149: GlaxoSmithKline Plc - Key news
Exhibits150: GlaxoSmithKline Plc - Key offerings
Exhibits151: GlaxoSmithKline Plc - Segment focus
Exhibits152: Hikma Pharmaceuticals Plc - Overview
Exhibits153: Hikma Pharmaceuticals Plc - Business segments
Exhibits154: Hikma Pharmaceuticals Plc - Key news
Exhibits155: Hikma Pharmaceuticals Plc - Key offerings
Exhibits156: Hikma Pharmaceuticals Plc - Segment focus
Exhibits157: Lupin Ltd. - Overview
Exhibits158: Lupin Ltd. - Product / Service
Exhibits159: Lupin Ltd. - Key news
Exhibits160: Lupin Ltd. - Key offerings
Exhibits161: Neopharma Corp. - Overview
Exhibits162: Neopharma Corp. - Product / Service
Exhibits163: Neopharma Corp. - Key news
Exhibits164: Neopharma Corp. - Key offerings
Exhibits165: Pfizer Inc. - Overview
Exhibits166: Pfizer Inc. - Product / Service
Exhibits167: Pfizer Inc. - Key news
Exhibits168: Pfizer Inc. - Key offerings
Exhibits169: Reckitt Benckiser Group Plc - Overview
Exhibits170: Reckitt Benckiser Group Plc - Business segments
Exhibits171: Reckitt Benckiser Group Plc - Key news
Exhibits172: Reckitt Benckiser Group Plc - Key offerings
Exhibits173: Reckitt Benckiser Group Plc - Segment focus
Exhibits174: Viatris Inc. - Overview
Exhibits175: Viatris Inc. - Business segments
Exhibits176: Viatris Inc. - Key news
Exhibits177: Viatris Inc. - Key offerings
Exhibits178: Viatris Inc. - Segment focus
Exhibits179: Inclusions checklist
Exhibits180: Exclusions checklist
Exhibits181: Currency conversion rates for US$
Exhibits182: Research methodology
Exhibits183: Information sources
Exhibits184: Data validation
Exhibits185: Validation techniques employed for market sizing
Exhibits186: Data synthesis
Exhibits187: 360 degree market analysis
Exhibits188: List of abbreviations

この商品のレポートナンバー

0000040566

TOP